Skip to main content
. 2021 Nov 18;11:763027. doi: 10.3389/fonc.2021.763027

Figure 6.

Figure 6

Immune functions (A) and expression of immune checkpoint inhibitors (B) between the high- and low-risk groups. *P < 0.05; **P < 0.01; ***P < 0.001.